The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of the presence of EGFR mutation on definitive chemoradiotherapy in patients with locally advanced non-small cell lung cancer: Pattern of relapses and survival analyses in 145 patients.
Shigehiro Yagishita
No relevant relationships to disclose
Hidehito Horinouchi
No relevant relationships to disclose
Tomoko Taniyama
No relevant relationships to disclose
Shinji Nakamichi
No relevant relationships to disclose
Satoru Kitazono
No relevant relationships to disclose
Hidenori Mizugaki
No relevant relationships to disclose
Shintaro Kanda
No relevant relationships to disclose
Yutaka Fujiwara
No relevant relationships to disclose
Hiroshi Nokihara
No relevant relationships to disclose
Noboru Yamamoto
No relevant relationships to disclose
Minako Sumi
No relevant relationships to disclose
Kouya Shiraishi
No relevant relationships to disclose
Takashi Kohno
No relevant relationships to disclose
Koh Furuta
No relevant relationships to disclose
Koji Tsuta
No relevant relationships to disclose
Tomohide Tamura
No relevant relationships to disclose